Exploring the Pharma Sector Breakout
Pharmaceutical sector nearing breakout on daily chart. Key stocks identified with BREAKOUT prices.

by RA ALOK DAIYA SEBI Reg. INH000011468

REPORT AS ON 28th Sep 2024
Sector Overview
Pharma sector showing strength. Poised for potential breakout.

1

Bullish Momentum
Sector gaining traction on daily charts.

2

Key Stocks
Six major pharmaceutical companies identified.

3

Breakout Levels
Specific price targets for each stock.
Dr. Reddy's Laboratories
Dr. Reddy's breakout price: 6800.
Global pharmaceutical company. Known for generic drugs, APIs.
Divi's Laboratories
Divi's Labs breakout price: 5500.
Specializes in manufacturing active pharmaceutical ingredients (APIs).
Torrent Pharmaceuticals
Torrent Pharma breakout price: 3525
Major player in cardiovascular, CNS, gastrointestinal therapeutics.
Lupin Limited
Lupin breakout price: 2250
Focuses on generics, specialty branded drugs.
Generics
Wide range of affordable medications.
Research
Innovative drug development programs.
Global
Strong presence in international markets.
Cipla
Cipla breakout price: 1690.
Known for respiratory, HIV/AIDS treatments.
Laurus Labs
Laurus Labs breakout price: 478.
Specializes in APIs, generic drug formulations.
1
Research
Innovative drug discovery and development.
2
Manufacturing
High-quality API production.
3
Distribution
Global supply chain network.
Disclaimer
This report is for informational purposes only. It does not constitute investment advice. We recommend that you consult with a financial professional before making any investment decisions.
The information contained herein is based on publicly available data and our own analysis. While we strive for accuracy, there may be errors or omissions. We are not responsible for any losses incurred as a result of using this information.
The performance of the pharmaceutical sector and the companies mentioned in this report may vary. Past performance is not necessarily indicative of future results.
We encourage you to conduct your own research and due diligence before making any investment decisions.